89 results
Page 2 of 5
8-K
EX-10.1
4prfe
3 Jan 22
Entry into a Material Definitive Agreement
7:00am
8-K
EX-99.1
snpxwxjvazaen3rqb8cs
30 Mar 21
Ovid Therapeutics Announces Closing of Agreement with Takeda for Global Development and Commercialization of Soticlestat
8:05am
8-K
EX-99.1
jeeuhhdr9o1
15 Mar 21
Ovid Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results, Provides Corporate Update for 2021
8:05am
8-K
q4d7qe31px8f 5nmoq9n
3 Mar 21
Entry into a Material Definitive Agreement
7:05am